Does microalbuminuria screening in diabetes prevent complications?

MOspace/Manakin Repository

Breadcrumbs Navigation

Does microalbuminuria screening in diabetes prevent complications?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/2927

[+] show full item record


Title: Does microalbuminuria screening in diabetes prevent complications?
Author: Hale, Wayne A.; Nashelsky, Joan
Keywords: nephropathy
renal failure
angiotensin receptor blockers (ARBs)
angiotensin-converting enzyme (ACE) inhibitors
Date: 2003-03
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 52(3) 2003: 229-231.
Abstract: Screening diabetic patients for microalbuminuria identifies those who may benefit from treatments that delay progression to renal failure (strength of recommendation: B, based on extrapolation from Level 1 treatment studies of patients with microalbuminuria). No research has determined the best method for screening for microalbuminuria, or whether screening in primary care populations will produce better long-term outcomes. No studies have examined the role of microalbuminuria screening after angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) have been instituted for other indications.
URI: http://hdl.handle.net/10355/2927

This item appears in the following Collection(s)

[+] show full item record